Guest commentary: Let’s not be fooled by gene therapy
Do we have to wait 500 years for medical progress to come from genetic research? Dr. Bryan Hanypsiak, director of medical education at Arthrex Inc., asserts that in his commentary opposing the Continue Reading
Therapy Shows Promise in Trials for Hereditary Cancer Patients
An emerging therapy that attacks cancer cells continues to show promise, most recently in two international studies on women who have breast and ovarian cancer and are carriers of cancer-causing Continue Reading
Venom-based nanoparticles improve gene therapy for glioma
An ingredient in the venom of the "deathstalker" scorpion could help gene therapy become an effective treatment for brain cancer, scientists are reporting. The substance allows therapeutic genes - Continue Reading
FDA approves longer Valcyte therapy for CMV disease in adult kidney transplant patients
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) approved increasing the length of therapy with Valcyte (valganciclovir hydrochloride) in Continue Reading
Stem cells may hold key for fatal skin disease
High-risk bone marrow transplants partially cured five children with a potentially deadly genetic defect in which proteins that hold layers of skin together are absent, U.S. researchers said Continue Reading
New laser technology for radiation therapy to destroy cancer cells
Currently, new treatment facilities for radiation therapy with ions are built all over the world. These particles destroy cancer cells and have a better ability to spare the surrounding healthy Continue Reading
Study To Examine Genotyping & Platelet Function Testing At Point-Of-Care To Personalize Anti-Platelet Therapy And …
A new study by the Center for Thrombosis Research at Sinai Hospital in Baltimore, MD will examine the utility of point-of-care genetic and platelet function testing to identify patients at risk for a Continue Reading
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver
shRNA overexpression from viral gene therapy vectors can trigger cytotoxicity leading to organ failure and lethality in mice and rats. This process likely involves saturation of endogenous cellular Continue Reading
Replacement Gene Therapy with a Human RPGRIP1 Sequence Slows Photoreceptor Degeneration in a Murine Model of Leber Congenital Amaurosis
Human Gene Therapy Aug 2010, Vol. 21, No. 8: 993-1004. (Source: Human Gene Therapy) Continue Reading
Analysis of Self-Inactivating Lentiviral Vector Integration Sites and Flanking Gene Expression in Human Peripheral Blood Progenitor Cells After Alkylator Chemotherapy
Human Gene Therapy Aug 2010, Vol. 21, No. 8: 943-956. (Source: Human Gene Therapy) Continue Reading
Deathstalker scorpion venom could improve gene therapy for brain cancer
(American Chemical Society) An ingredient in the venom of the "deathstalker" scorpion could help gene therapy become an effective treatment for brain cancer, scientists are reporting. The substance Continue Reading
Enhancement of gene targeting in human cells by intranuclear permeation of the Saccharomyces cerevisiae Rad52 protein
The introduction of exogenous DNA in human somatic cells results in a frequency of random integration at least 100-fold higher than gene targeting (GT), posing a seemingly insurmountable limitation Continue Reading
Parent Project Muscular Dystrophy Awards $600K To Nationwide Children’s Hospital For Gene Therapy Study
Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced that PPMD will award Continue Reading
Study finds hormone replacement therapy increases breast cancer risk
A new analysis of the California Teachers Study, which analyzed hormone replacement therapy use among 2,857 women for almost 10 years, underscores the need for personalized risk-benefit discussions Continue Reading
Parent Project Muscular Dystrophy awards $600K to Nationwide Children’s for gene therapy study
(Nationwide Children's Hospital) Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy, announced that Continue Reading
New Drug Reduces Tumor Size in Women with Advanced Hereditary Ovarian Or Breast Cancer
Understanding the underlying genetic weakness of certain types of cancer may lead to targeted therapy and provide the key to effective treatment, a new study suggests. An international consortium of Continue Reading
Therapy dogs making a difference in lives of young readers with autism
The bond between autistic children and Mattilda the Dalmatian can be nothing short of magical, said Mattilda’s owner, Stephanie Cooper-Greenberg. Children who are normally too shy or afraid to read Continue Reading
Neurologix Reports Second Quarter 2010 Financial Results
FORT LEE, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Neurologix, Inc. (OTCBB: NRGX) (the "Company"), a biotechnology company developing innovative gene therapies for the brain and central nervous system Continue Reading
Interleukin Genetics, University of Michigan to conduct landmark clinical study on periodontal disease
Interleukin Genetics, Inc. announced today that the Company has signed an agreement with the University of Michigan to conduct a landmark clinical study on risk factors predictive of periodontal Continue Reading
‘Deathstalker’ scorpion venom could improve anti-brain cancer gene therapy
Washington, Aug 12 : Scientists have found that an ingredient in the venom of the 'deathstalker' scorpion could help gene therapy become an effective treatment for brain cancer. Continue Reading
